Clinical Trials

Accrual Status
Limit to SWOG Trials

647 Results

View
Status Trial Number Title Activated Closed Accrual Phase Published
Closed S0905 Ph I / Randomized Ph II Mesothelioma Cediranib 3/15/2010 2/15/2016 91% Published
Closed S1202 Ph III Study of Duloxetine for AI-associated musculoskleteal symptoms for Early Stage BrCa 5/15/2013 10/1/2015 100% Published
Closed S0000B SELECT Eye Endpoints (SEE) 7/1/2004 7/31/2015 Published
Closed S0819 Phase III Carbo/Taxol/Bevacizumab +/- Cetuximab in Advanced NSCLC 7/15/2009 5/1/2015 78% Published
Closed S1117 Rando PII Aza vs. Aza/Len vs. Aza/Vorin for High Risk MDS and CMML 3/1/2012 11/14/2014 100% Published
Closed S0709 Phase II Carboplatin/Paclitaxel/Erlotinib vs Erlotinib Alone in Advanced NSCLC 12/1/2008 9/15/2014 54% Published
Closed S1115 Rando Phase II of AZD-6244 add MK-2206 vs mFOLFOX in Pts with Met Pancreatic Cancer After Chemo 8/15/2012 5/15/2014 100% Published
Closed S0702 CANCER CONTROL: Prospective ONJ Trial 12/15/2008 12/13/2013 100% Published
Closed S0806 Phase I/II DLBCL Vorinostat with R-CHOP 11/15/2010 10/1/2013 100% Published
Closed S1119 Water Contamination Study 12/2/2011 8/5/2013 100% Published
Closed S1014 Metastatic PCa Suboptimal Response ADT, Abiraterone Acetate, Ph II 8/9/2011 8/1/2013 98% Published
Closed S1106 Randomized Phase II Younger Patients Mantle Cell Lymphoma 10/1/2011 6/26/2013 29% Published
Closed S1108 Phase II MLN8237 in Peripheral T-Cell NHL 10/28/2011 6/6/2013 100% Published
Closed S0000D Adenomatous Colorectal Polyps (ACP) 6/3/2008 5/28/2013 100% Published
Closed S1005 Ph II MK-2206 gastric and GEJ 1/1/2011 5/1/2013 100% Published
Closed S0713 Ph II Rectal Pre-Operative ChemoRT 2/1/2009 4/15/2013 94% Published
Closed S0927 Ph III Omega-3 fatty acid/placebo Breast Cancer 2/1/2012 2/1/2013 100% Published
Closed S0816 Phase II Stage III-IV Hodgkin's: FDG-PET Imaging Study 7/1/2009 12/1/2012 100% Published
Closed S0925 New Hormone-Sensitive Metastatic PCa, Androgen Deprivation +/- IMC-A12, Ph II 12/15/2010 12/1/2012 100% Published
Closed S0809 Cholangiocarcinoma Ph II capecitabine, gemcitabine, RT 12/1/2008 10/1/2012 100% Published
Scroll Table